NAC to Prevent Cisplatin-induced Hearing Loss

Clinical trial NCT02094625 · COMPLETED

Trial details

NCT number: NCT02094625
Sponsor: Children's Hospital Los Angeles
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroectodermal Tumors, Primitive Liver Neoplasms Osteosarcoma Other Childhood Cancers Using Cisplatin-based Regimens

Start date: 2016-03-01
Primary completion: 2020-09-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.